Cancer cachexia: molecular mechanisms and treatment strategies

T Setiawan, IN Sari, YT Wijaya, NM Julianto… - Journal of Hematology & …, 2023 - Springer
Muscle wasting is a consequence of physiological changes or a pathology characterized by
increased catabolic activity that leads to progressive loss of skeletal muscle mass and …

Muscle-to-tumor crosstalk: The effect of exercise-induced myokine on cancer progression

Q Huang, M Wu, X Wu, Y Zhang, Y Xia - Biochimica et Biophysica Acta …, 2022 - Elsevier
Physical exercise has gradually become a focus in cancer treatment due to its pronounced
role in reducing cancer risk, enhancing therapeutic efficacy, and improving prognosis. In …

Molecular mechanisms of cancer cachexia‐related loss of skeletal muscle mass: data analysis from preclinical and clinical studies

A Martin, YS Gallot, D Freyssenet - Journal of Cachexia …, 2023 - Wiley Online Library
Cancer cachexia is a systemic hypoanabolic and catabolic syndrome that diminishes the
quality of life of cancer patients, decreases the efficiency of therapeutic strategies and …

Chemotherapy impairs skeletal muscle mitochondrial homeostasis in early breast cancer patients

J Mallard, E Hucteau, AL Charles… - Journal of cachexia …, 2022 - Wiley Online Library
Background Chemotherapy is extensively used to treat breast cancer and is associated with
skeletal muscle deconditioning, which is known to reduce patients' quality of life, treatment …

Chemotherapy-induced myopathy: the dark side of the cachexia sphere

DG Campelj, CA Goodman, E Rybalka - Cancers, 2021 - mdpi.com
Simple Summary In addition to cancer-related factors, anti-cancer chemotherapy treatment
can drive life-threatening body wasting in a syndrome known as cachexia. Emerging …

Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B‐cell lymphoma

SI Go, MJ Park, S Park, MH Kang… - Journal of Cachexia …, 2021 - Wiley Online Library
Background Cancer cachexia is known to adversely affect the clinical course in patients with
malignant lymphoma. The cachexia index (CXI) is a potential biomarker of cancer cachexia …

Mitochondrial dysfunction and skeletal muscle atrophy: Causes, mechanisms, and treatment strategies

GB Kubat, E Bouhamida, O Ulger, I Turkel, G Pedriali… - Mitochondrion, 2023 - Elsevier
Skeletal muscle, which accounts for approximately 40% of total body weight, is one of the
most dynamic and plastic tissues in the human body and plays a vital role in movement …

Cholic and deoxycholic acids induce mitochondrial dysfunction, impaired biogenesis and autophagic flux in skeletal muscle cells

J Abrigo, H Olguín, F Tacchi, J Orozco-Aguilar… - Biological Research, 2023 - Springer
Background Skeletal muscle is sensitive to bile acids (BA) because it expresses the TGR5
receptor for BA. Cholic (CA) and deoxycholic (DCA) acids induce a sarcopenia-like …

Chemotherapy-induced molecular changes in skeletal muscle

MB Pedrosa, S Barbosa, R Vitorino, R Ferreira… - Biomedicines, 2023 - mdpi.com
Paraneoplastic conditions such as cancer cachexia are often exacerbated by chemotherapy,
which affects the patient's quality of life as well as the response to therapy. The aim of this …

Inflammation o'clock: interactions of circadian rhythms with inflammation‐induced skeletal muscle atrophy

F Morena da Silva, KA Esser, KA Murach… - The Journal of …, 2023 - Wiley Online Library
Circadian rhythms are∼ 24 h cycles evident in behaviour, physiology and metabolism. The
molecular mechanism directing circadian rhythms is the circadian clock, which is composed …